ROHTO PHARMA, Oct-Dec (3Q) Ordinary Profit Increases by 2%, Current Fiscal Year Dividend Revised Upward by 3 yen

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Feb 12, 2025 3:30 pm JST Earnings

4527 ROHTO PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

ROHTO PHARMACEUTICAL CO.,LTD. <4527> [TSE Prime] announced its financial results after the market closed on February 12th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2025 (April to December) decreased 10.4% from the same period last year to 33.3 billion yen. The progress rate toward the full-year plan of 44.2 billion yen was 75.5%, below the five-year average of 80.5%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to surge 2.1 times that of the same period last year, reaching 10.8 billion yen.

At the same time, the company has increased its planned annual dividend for the current fiscal year from the original plan of 33 yen to 36 yen (compared to 27 yen in the previous period).

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit amounted to 14.7 billion yen, an increase of 1.5% compared to the same period last year. However, the operating profit margin decreased from 19.5% in the same period last year to 16.7%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	176,263	28,598	29,540	21,637	94.8	83.1	Feb 13, 2023	J-GAAP
Apr - Dec, 2023	201,163	35,262	37,247	26,157	114.7	87.8	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	225,895	32,267	33,383	24,806	108.7	75.5	Feb 12, 2025	J-GAAP
YoY	+12.3%	-8.5%	-10.4%	-5.2%	-5.2%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	180,918	25,409	25,610	19,279	85.3	17	Nov 13, 2024	J-GAAP
Oct - Mar, 2024 New	180,918	25,409	25,610	19,279	85.3	20	Feb 12, 2025	J-GAAP
Revision Rate	0.0%	0.0%	0.0%	0.0%	0.0%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	320,000	43,200	44,200	32,200	142.5	33	Aug 7, 2024	J-GAAP
Mar, 2025 New	320,000	43,200	44,200	32,200	142.5	36	Feb 12, 2025	J-GAAP
Revision Rate	0.0%	0.0%	0.0%	0.0%	0.0%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	142,971	19,082	19,756	14,342	62.9	15	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	180,918	25,409	25,610	19,279	85.3	20	Feb 12, 2025	J-GAAP
YoY	+26.5%	+33.2%	+29.6%	+34.4%	+35.7%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	238,664	33,959	35,568	26,377	115.6	22	May 12, 2023	J-GAAP
Mar, 2024	270,840	40,048	42,434	30,936	135.6	27	May 13, 2024	J-GAAP
Mar, 2025 Guidance	320,000	43,200	44,200	32,200	142.5	36	Feb 12, 2025	J-GAAP
YoY	+18.2%	+7.9%	+4.2%	+4.1%	+5.1%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	73,294	14,296	14,569	9,563	41.9	19.5	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	69,677	4,786	5,187	4,779	21.0	6.9	May 13, 2024	J-GAAP
Apr - Jun, 2024	68,356	11,790	12,273	8,482	37.2	17.2	Aug 7, 2024	J-GAAP
Jul - Sep, 2024	70,726	6,001	6,317	4,439	19.5	8.5	Nov 13, 2024	J-GAAP
Oct - Dec, 2024	86,813	14,476	14,793	11,885	52.1	16.7	Feb 12, 2025	J-GAAP
YoY	+18.4%	+1.3%	+1.5%	+24.3%	+24.3%